162 results
Page 2 of 9
8-K
EX-1.1
sjh1o16i2e22zvk3q
14 Sep 22
Entry into a Material Definitive Agreement
9:01am
424B5
jxh9jzg7bxbotwhf
14 Sep 22
Prospectus supplement for primary offering
7:28am
8-K
EX-99.1
2r7o cpibjv
25 Mar 22
Larimar Therapeutics Reports Fourth Quarter and Full Year 2021 Operating and Financial Results
7:11am
8-K
EX-99.1
vxsee1
12 Aug 21
Larimar Therapeutics Reports Second Quarter 2021 Operating and Financial Results
10:29am
8-K
EX-4.1
dfaq9n
21 May 21
Entry into a Material Definitive Agreement
9:30am
8-K
EX-10.3
yohk1c j3l
21 May 21
Entry into a Material Definitive Agreement
9:30am
8-K
EX-10.2
37ia kcryx
21 May 21
Entry into a Material Definitive Agreement
9:30am
8-K
EX-99.1
l6q5weemv yscglk1
21 May 21
Larimar Therapeutics Receives European Medicines Agency Priority Medicines (PRIME) Designation for CTI-1601 in Friedreich’s Ataxia
7:28am